Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00598728 · ClinicalTrials.gov registry record
Quality of Life Among Survivors of Hodgkin Lymphoma
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 255
- Enrollment target
NCT00598728: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00598728 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 255 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00598728 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 255 participants
- Enrollment target
Study Summary
The purpose of this study is to collect information on the long-term side effects of treatment for Hodgkin Lymphoma. We hope to study about 500-800 survivors of Hodgkin Lymphoma. We plan to use the findings from this study to better understand Hodgkin Lymphoma survivors' health and quality of life.
Interventions
- BEHAVIORAL Quality of Life Questionaires
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 255 participants |
| Start Date | 2005-05 |
| Est. Completion | 2016-04 |
What the finished NCT00598728 record still lists
NCT00598728 is an observational study that tracks outcomes without assigning an intervention. The registered 255 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Quality of Life Questionaires is the first listed.
NCT00598728 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00598728 about?
NCT00598728 is a clinical study titled "Quality of Life Among Survivors of Hodgkin Lymphoma". The purpose of this study is to collect information on the long-term side effects of treatment for Hodgkin Lymphoma. We hope to study about 500-800 survivors of Hodgkin Lymphoma. We plan to use the findings from this study to better understand Hodgkin Lymphoma survivors' health and quality of life.
What is the current status of trial NCT00598728?
This trial is currently completed. The enrollment target is 255 participants. The study started on 2005-05. Estimated completion is 2016-04.
What interventions are being tested in trial NCT00598728?
The interventions under investigation include: Quality of Life Questionaires (BEHAVIORAL).
Who is sponsoring clinical trial NCT00598728?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04623424 · 255 participants
Intestinal Microbiota in Stem Cell Transplant Transplant Admission
- NCT05114798 · 255 participants · NA
Time-restricted Eating Versus Daily Continuous Calorie Restriction on Body Weight and Colorectal Cancer Risk Markers
- NCT05336188 · 255 participants · Phase 2
Neurocognitive Mechanisms Underlying Smartphone-Assisted Prevention of Relapse in Opioid Use Disorder
- NCT05486637 · 255 participants · Early Phase 1
Vocal Emotion Communication With Cochlear Implants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia